In the study by Bala and colleagues,1 it seems that interpretations on cost effectiveness of palivizumab are made based on the number of admissions for bronchiolitis alone.
We conducted an epidemiological study to determine the importance of respiratory syncytial virus (RSV) in the region on 412 …
CiteULike
Connotea
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
Technorati
TwitterCiteULikeConnoteaDeliciousDiggFacebookGoogle+MendeleyRedditTechnoratiTwitter
Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ADC
Fetal & Neonatal.
View free sample issue >>
Free archive
The full back archive is now available for ADC Fetal & Neonatal. Institutional subscribers may access the entire archive as
part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who
register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Online ISSN 1468-2052
Copyright © 2012 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health. All rights reserved.
